Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo
Clinical trial NCT00739986 · COMPLETED
Trial details
- NCT number
- NCT00739986
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-10-01
- Primary completion
- 2004-06-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.